Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release (NCT00367302) | Clinical Trial Compass
CompletedPhase 1/2
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release
116 participantsStarted 2006-08
Plain-language summary
The purpose of the study is to determine the feasibility of providing buprenorphine maintenance to opioid-dependent offenders in a jail setting and of transitioning those patients to buprenorphine maintenance in the community after their release.
Who can participate
Age range18 Years – 65 Years
SexMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* opioid dependent patients who meet eligibility requirements for the KEEP program,
* patients serving sentences who will remain confined for at least 10 days but less than 90 days in the EMTC facility (all male) at Rikers,
* willingness to accept buprenorphine treatment,
* expected to reside in New York City after release
* 18-65 years of age
Exclusion Criteria:
* receiving methadone treatment in the community at sentencing and remanded to Rikers
* took non-prescribed 'street methadone' within last 3 days
* currently receiving more than 20mg/day methadone
* current psychotic symptoms (e.g., schizophrenia, schizoaffective disorder) requiring referral for mental health intervention, or current treatment with antipsychotic medication)
* HIV infection with T lymphocytes less than 200 per mm of blood and/or presence of a serious opportunistic infection requiring treatment, or receiving the HIV medication atazanavir.
* unable to complete English language interview
What they're measuring
1
Treatment completion in jail
Timeframe: Until release from jail
2
Reporting to assigned treatment modality after release
Timeframe: Within 3 months after release from jail
Trial details
NCT IDNCT00367302
SponsorNational Development and Research Institutes, Inc.